| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board
|
|
|
|
4 |
4 |
p. ii
|
artikel
|
| 2 |
Efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma treatment in patients aged ≥80 years
|
Tsuchiya, Kyohei
|
|
|
4 |
4 |
p. 206-211
|
artikel
|
| 3 |
Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
|
Shih, Tsung-Chieh
|
|
|
4 |
4 |
p. 168-172
|
artikel
|
| 4 |
Golgi protein 73, hepatocellular carcinoma and other types of cancers
|
Wang, Yanan
|
|
|
4 |
4 |
p. 161-167
|
artikel
|
| 5 |
Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies
|
Colquhoun, Steven D.
|
|
|
4 |
4 |
p. 180-190
|
artikel
|
| 6 |
Hepatocellular carcinoma diagnosis and treatment: An overview
|
Colquhoun, Steven D.
|
|
|
4 |
4 |
p. 159-160
|
artikel
|
| 7 |
Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome
|
Vaziri, Farzam
|
|
|
4 |
4 |
p. 191-198
|
artikel
|
| 8 |
Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
|
Setayesh, Tahereh
|
|
|
4 |
4 |
p. 173-179
|
artikel
|
| 9 |
Relationship between outcomes and relative dose intensity of lenvatinib treatment in patients with advanced hepatocellular carcinoma
|
Ohki, Takamasa
|
|
|
4 |
4 |
p. 199-205
|
artikel
|
| 10 |
Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization
|
Xia Qian,
|
|
|
4 |
4 |
p. 212-217
|
artikel
|
Tijdschrift beschrijving